BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mazzetti S, Basellini MJ, Ferri V, Cassani E, Cereda E, Paolini M, Calogero AM, Bolliri C, De Leonardis M, Sacilotto G, Cilia R, Cappelletti G, Pezzoli G. α-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson's disease. Brain 2020;143:920-31. [PMID: 32025699 DOI: 10.1093/brain/awaa008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Sekiya H, Tsuji A, Hashimoto Y, Takata M, Koga S, Nishida K, Futamura N, Kawamoto M, Kohara N, Dickson DW, Kowa H, Toda T. Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson's disease. Acta Neuropathol Commun 2022;10:133. [PMID: 36068646 DOI: 10.1186/s40478-022-01440-6] [Reference Citation Analysis]
2 Semenova EI, Vlasov IN, Partevian SA, Rosinskaya AV, Rybolovlev IN, Slominsky PA, Shadrina MI, Alieva AK. Transcriptome Profiling Reveals Differential Expression of Circadian Behavior Genes in Peripheral Blood of Monozygotic Twins Discordant for Parkinson's Disease. Cells 2022;11:2599. [PMID: 36010675 DOI: 10.3390/cells11162599] [Reference Citation Analysis]
3 Zheng Y, Yu Z, Zhao J, Cai H, Wang Z, Wang X, Feng T. Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease. Front Aging Neurosci 2022;14:867528. [DOI: 10.3389/fnagi.2022.867528] [Reference Citation Analysis]
4 Mazzetti S, Barichella M, Giampietro F, Giana A, Calogero AM, Amadeo A, Palazzi N, Comincini A, Giaccone G, Bramerio M, Caronni S, Cereda V, Cereda E, Cappelletti G, Rolando C, Pezzoli G. Astrocytes expressing Vitamin D-activating enzyme identify Parkinson's disease. CNS Neurosci Ther 2022. [PMID: 35166042 DOI: 10.1111/cns.13801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Signaevsky M, Marami B, Prastawa M, Tabish N, Iida MA, Zhang XF, Sawyer M, Duran I, Koenigsberg DG, Bryce CH, Chahine LM, Mollenhauer B, Mosovsky S, Riley L, Dave KD, Eberling J, Coffey CS, Adler CH, Serrano GE, White CL 3rd, Koll J, Fernandez G, Zeineh J, Cordon-Cardo C, Beach TG, Crary JF. Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence. Acta Neuropathol Commun 2022;10:21. [PMID: 35164870 DOI: 10.1186/s40478-022-01318-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Oliveira JT, Dakic V, Vitória G, Pedrosa CDS, Mendes M, Aragão LGH, Cardim-pires TR, Lelièvre D, Furtado DR, Pinheiro RO, Foguel D, Breton L, Bouez C, De Vecchi R, Guimarães MZP, Rehen S. Oligomeric α-Synuclein induces skin degeneration in reconstructed human epidermis. Neurobiology of Aging 2022. [DOI: 10.1016/j.neurobiolaging.2022.02.010] [Reference Citation Analysis]
7 Vacchi E, Senese C, Chiaro G, Disanto G, Pinton S, Morandi S, Bertaina I, Bianco G, Staedler C, Galati S, Gobbi C, Kaelin-Lang A, Melli G. Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson's disease. NPJ Parkinsons Dis 2021;7:119. [PMID: 34930911 DOI: 10.1038/s41531-021-00262-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Koga S, Sekiya H, Kondru N, Ross OA, Dickson DW. Neuropathology and molecular diagnosis of Synucleinopathies. Mol Neurodegener 2021;16:83. [PMID: 34922583 DOI: 10.1186/s13024-021-00501-z] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
9 Vlasov IN, Alieva AK, Novosadova EV, Arsenyeva EL, Rosinskaya AV, Partevian SA, Grivennikov IA, Shadrina MI. Transcriptome Analysis of Induced Pluripotent Stem Cells and Neuronal Progenitor Cells, Derived from Discordant Monozygotic Twins with Parkinson's Disease. Cells 2021;10:3478. [PMID: 34943986 DOI: 10.3390/cells10123478] [Reference Citation Analysis]
10 Kuzkina A, Bargar C, Schmitt D, Rößle J, Wang W, Schubert AL, Tatsuoka C, Gunzler SA, Zou WQ, Volkmann J, Sommer C, Doppler K, Chen SG. Diagnostic value of skin RT-QuIC in Parkinson's disease: a two-laboratory study. NPJ Parkinsons Dis 2021;7:99. [PMID: 34782640 DOI: 10.1038/s41531-021-00242-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
11 De Miranda BR, Goldman SM, Miller GW, Greenamyre JT, Dorsey ER. Preventing Parkinson's Disease: An Environmental Agenda. J Parkinsons Dis 2021. [PMID: 34719434 DOI: 10.3233/JPD-212922] [Reference Citation Analysis]
12 Sharabi Y, Vatine GD, Ashkenazi A. Parkinson's disease outside the brain: targeting the autonomic nervous system. Lancet Neurol 2021;20:868-76. [PMID: 34536407 DOI: 10.1016/S1474-4422(21)00219-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Amadeo A, Pizzi S, Comincini A, Modena D, Calogero AM, Madaschi L, Faustini G, Rolando C, Bellucci A, Pezzoli G, Mazzetti S, Cappelletti G. The Association between α-Synuclein and α-Tubulin in Brain Synapses. Int J Mol Sci 2021;22:9153. [PMID: 34502063 DOI: 10.3390/ijms22179153] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ganguly U, Singh S, Pal S, Prasad S, Agrawal BK, Saini RV, Chakrabarti S. Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough. Front Aging Neurosci 2021;13:702639. [PMID: 34305577 DOI: 10.3389/fnagi.2021.702639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ray B, Mahalakshmi AM, Tuladhar S, Bhat A, Srinivasan A, Pellegrino C, Kannan A, Bolla SR, Chidambaram SB, Sakharkar MK. "Janus-Faced" α-Synuclein: Role in Parkinson's Disease. Front Cell Dev Biol 2021;9:673395. [PMID: 34124057 DOI: 10.3389/fcell.2021.673395] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
16 Stuendl A, Kraus T, Chatterjee M, Zapke B, Sadowski B, Moebius W, Hobert MA, Deuschle C, Brockmann K, Maetzler W, Mollenhauer B, Schneider A. α-Synuclein in Plasma-Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease. Mov Disord 2021. [PMID: 34002893 DOI: 10.1002/mds.28639] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Andréasson M, Svenningsson P. Update on alpha-synuclein-based biomarker approaches in the skin, submandibular gland, gastrointestinal tract, and biofluids. Curr Opin Neurol 2021;34:572-7. [PMID: 33967199 DOI: 10.1097/WCO.0000000000000948] [Reference Citation Analysis]
18 Bengoa-Vergniory N, Velentza-Almpani E, Silva AM, Scott C, Vargas-Caballero M, Sastre M, Wade-Martins R, Alegre-Abarrategui J. Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease. Acta Neuropathol Commun 2021;9:18. [PMID: 33509301 DOI: 10.1186/s40478-020-01117-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
19 Musteikytė G, Jayaram AK, Xu CK, Vendruscolo M, Krainer G, Knowles TPJ. Interactions of α-synuclein oligomers with lipid membranes. Biochim Biophys Acta Biomembr 2021;1863:183536. [PMID: 33373595 DOI: 10.1016/j.bbamem.2020.183536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
20 Niemann N, Billnitzer A, Jankovic J. Parkinson's disease and skin. Parkinsonism Relat Disord 2021;82:61-76. [PMID: 33248395 DOI: 10.1016/j.parkreldis.2020.11.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Dulovic-Mahlow M, König IR, Trinh J, Diaw SH, Urban PP, Knappe E, Kuhnke N, Ingwersen LC, Hinrichs F, Weber J, Kupnicka P, Balck A, Delcambre S, Vollbrandt T, Grünewald A, Klein C, Seibler P, Lohmann K. Discordant Monozygotic Parkinson Disease Twins: Role of Mitochondrial Integrity. Ann Neurol 2021;89:158-64. [PMID: 33094862 DOI: 10.1002/ana.25942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Manne S, Kondru N, Jin H, Serrano GE, Anantharam V, Kanthasamy A, Adler CH, Beach TG, Kanthasamy AG. Blinded RT-QuIC Analysis of α-Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients. Mov Disord 2020;35:2230-9. [PMID: 32960470 DOI: 10.1002/mds.28242] [Cited by in Crossref: 19] [Cited by in F6Publishing: 40] [Article Influence: 9.5] [Reference Citation Analysis]
23 Kühn E, Averdunk P, Huckemann S, Müller K, Biesalski AS, Hof Zum Berge F, Motte J, Fisse AL, Schneider-Gold C, Gold R, Pitarokoili K, Tönges L. Correlates of polyneuropathy in Parkinson's disease. Ann Clin Transl Neurol 2020;7:1898-907. [PMID: 32940017 DOI: 10.1002/acn3.51182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Wändell P, Fredrikson S, Carlsson AC, Li X, Sundquist J, Sundquist K. Parkinson's Disease Among Immigrant Groups and Swedish-Born Individuals: A Cohort Study of All Adults 50 Years of Age and Older in Sweden. J Parkinsons Dis 2020;10:1133-41. [PMID: 32568106 DOI: 10.3233/JPD-201962] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Vacchi E, Kaelin-Lang A, Melli G. Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core. Int J Mol Sci 2020;21:E5030. [PMID: 32708732 DOI: 10.3390/ijms21145030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]